Elevated levels of CD4+CD25+ regulatory T (Treg) cells, which were first reported in patients with lung and ovarian cancers by Woo et al. [41,42] following their discovery in 1995 [43], have been found to be implicated in tumour immune evasion [44,45,46,47,48]. Here, CD4 is linked to neoplasm.